BASEL, Switzerland--(BUSINESS WIRE)--Syngenta, a world leader in developing the next generation of biologicals products for agricultural use, is significantly expanding its biologicals research and development capabilities. Today, it announced that it has acquired the Novartis repository of natural compounds and genetic strains for agricultural use, while Novartis maintains exclusive rights to repository for pharmaceutical use. The transaction also includes transfer of the Novartis Natural Prod...
Read the full news release here
